PL3829563T3 - Kwas 3-sulfopropanowy do leczenia zaburzeń neurodegeneracyjnych - Google Patents
Kwas 3-sulfopropanowy do leczenia zaburzeń neurodegeneracyjnychInfo
- Publication number
- PL3829563T3 PL3829563T3 PL19752795.5T PL19752795T PL3829563T3 PL 3829563 T3 PL3829563 T3 PL 3829563T3 PL 19752795 T PL19752795 T PL 19752795T PL 3829563 T3 PL3829563 T3 PL 3829563T3
- Authority
- PL
- Poland
- Prior art keywords
- neurodegenerative disorders
- treating neurodegenerative
- sulfopropanoic acid
- sulfopropanoic
- acid
- Prior art date
Links
- OURSFPZPOXNNKX-UHFFFAOYSA-N 3-sulfopropanoic acid Chemical compound OC(=O)CCS(O)(=O)=O OURSFPZPOXNNKX-UHFFFAOYSA-N 0.000 title 1
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862713061P | 2018-08-01 | 2018-08-01 | |
| PCT/US2019/044023 WO2020028290A1 (en) | 2018-08-01 | 2019-07-30 | Methods for treating neurodegenerative disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3829563T3 true PL3829563T3 (pl) | 2025-04-07 |
Family
ID=67614642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19752795.5T PL3829563T3 (pl) | 2018-08-01 | 2019-07-30 | Kwas 3-sulfopropanowy do leczenia zaburzeń neurodegeneracyjnych |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US12083082B2 (pl) |
| EP (1) | EP3829563B1 (pl) |
| JP (1) | JP7573512B2 (pl) |
| KR (1) | KR102716959B1 (pl) |
| CN (1) | CN112867485A (pl) |
| AU (1) | AU2019315853B2 (pl) |
| BR (1) | BR112021001739A2 (pl) |
| CL (1) | CL2021000269A1 (pl) |
| DK (1) | DK3829563T3 (pl) |
| EA (1) | EA202190406A1 (pl) |
| ES (1) | ES3011716T3 (pl) |
| FI (1) | FI3829563T3 (pl) |
| HR (1) | HRP20250206T1 (pl) |
| HU (1) | HUE070101T2 (pl) |
| IL (1) | IL280424B2 (pl) |
| LT (1) | LT3829563T (pl) |
| MX (1) | MX2021001287A (pl) |
| MY (1) | MY206530A (pl) |
| PH (1) | PH12021550213A1 (pl) |
| PL (1) | PL3829563T3 (pl) |
| PT (1) | PT3829563T (pl) |
| RS (1) | RS66516B1 (pl) |
| SG (1) | SG11202100767XA (pl) |
| SI (1) | SI3829563T1 (pl) |
| SM (1) | SMT202500080T1 (pl) |
| UA (1) | UA130011C2 (pl) |
| WO (1) | WO2020028290A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3829563T3 (en) * | 2018-08-01 | 2025-02-24 | Alzheon Inc | 3-sulfopropanoic acid for treating neurodegenerative disorders |
| JP2022536803A (ja) * | 2019-06-17 | 2022-08-18 | アルツェオン・インコーポレーテッド | 神経変性障害を治療する方法 |
| IL313404A (en) * | 2021-12-09 | 2024-08-01 | Alzheon Inc | ALZ-801 for use in the treatment of Alzheimer's disease |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5840294A (en) * | 1993-03-29 | 1998-11-24 | Queen's University At Kingston | Method for treating amyloidosis |
| KR101608445B1 (ko) | 2006-10-12 | 2016-04-01 | 비에이치아이 리미티드 파트너쉽 | 3-아미노-1-프로판설폰산을 전달하기 위한 방법, 화합물, 조성물 및 비히클 |
| EP2852388A4 (en) | 2012-05-23 | 2016-01-13 | Univ Johns Hopkins | COMPOUNDS AND METHOD FOR USE THEREOF FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES |
| US20150359849A1 (en) | 2013-01-31 | 2015-12-17 | President And Fellows Of Harvard College | Methods of increasing neuronal connectivity and/or treating a neurodegenerative condition |
| WO2015143447A2 (en) * | 2014-03-21 | 2015-09-24 | Alzheon, Inc. | Methods for treating neurological disorders |
| PT3347002T (pt) | 2015-09-10 | 2023-07-27 | Alzheon Inc | Tratamento de doença de alzheimer numa população particular de pacientes |
| DK3829563T3 (en) * | 2018-08-01 | 2025-02-24 | Alzheon Inc | 3-sulfopropanoic acid for treating neurodegenerative disorders |
-
2019
- 2019-07-30 DK DK19752795.5T patent/DK3829563T3/da active
- 2019-07-30 EA EA202190406A patent/EA202190406A1/ru unknown
- 2019-07-30 JP JP2021505721A patent/JP7573512B2/ja active Active
- 2019-07-30 MY MYPI2021000515A patent/MY206530A/en unknown
- 2019-07-30 US US17/264,477 patent/US12083082B2/en active Active
- 2019-07-30 SI SI201930898T patent/SI3829563T1/sl unknown
- 2019-07-30 UA UAA202101015A patent/UA130011C2/uk unknown
- 2019-07-30 WO PCT/US2019/044023 patent/WO2020028290A1/en not_active Ceased
- 2019-07-30 HU HUE19752795A patent/HUE070101T2/hu unknown
- 2019-07-30 FI FIEP19752795.5T patent/FI3829563T3/fi active
- 2019-07-30 IL IL280424A patent/IL280424B2/en unknown
- 2019-07-30 RS RS20250164A patent/RS66516B1/sr unknown
- 2019-07-30 KR KR1020217005803A patent/KR102716959B1/ko active Active
- 2019-07-30 CN CN201980064415.6A patent/CN112867485A/zh active Pending
- 2019-07-30 ES ES19752795T patent/ES3011716T3/es active Active
- 2019-07-30 BR BR112021001739-9A patent/BR112021001739A2/pt unknown
- 2019-07-30 PT PT197527955T patent/PT3829563T/pt unknown
- 2019-07-30 MX MX2021001287A patent/MX2021001287A/es unknown
- 2019-07-30 PL PL19752795.5T patent/PL3829563T3/pl unknown
- 2019-07-30 EP EP19752795.5A patent/EP3829563B1/en active Active
- 2019-07-30 SM SM20250080T patent/SMT202500080T1/it unknown
- 2019-07-30 AU AU2019315853A patent/AU2019315853B2/en active Active
- 2019-07-30 SG SG11202100767XA patent/SG11202100767XA/en unknown
- 2019-07-30 HR HRP20250206TT patent/HRP20250206T1/hr unknown
- 2019-07-30 LT LTEPPCT/US2019/044023T patent/LT3829563T/lt unknown
-
2021
- 2021-01-28 PH PH12021550213A patent/PH12021550213A1/en unknown
- 2021-02-01 CL CL2021000269A patent/CL2021000269A1/es unknown
-
2024
- 2024-08-02 US US18/793,452 patent/US20250213507A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL279308A (en) | Methods for the treatment of heptidine-mediated disorders | |
| IL256380A (en) | Vesicular monoamine transporter 2 inhibitors for the treatment of neurological diseases or disorders | |
| IL262222A (en) | Anti-aging antibodies for the treatment of neurodegenerative disorders | |
| SMT201900172T1 (it) | Ammino triazoli sostituiti utili come inibitori della chitinasi umana | |
| IL281052A (en) | Treatment of liver disorders | |
| PT4088720T (pt) | Rimegepant para distúrbios relacionados com o cgrp | |
| HUE056356T2 (hu) | Tetrahidro-8H-pirido[1,2-a]pirazin-8-on vegyületek, mint COMT inhibitorok neurodegeneratív rendellenességek kezelésére | |
| GB201803010D0 (en) | Neurodegenerative disorders | |
| ZA201800831B (en) | Compositions and methods for treating and preventing neurodegenerative disorders | |
| ZA201907238B (en) | Compositions for treating neurodegenerative diseases | |
| IL280424A (en) | Methods for treating neurodegenerative disorders | |
| SG11202007286TA (en) | Methods for treating mitochondrial disorders | |
| DK4296670T3 (en) | Sulfopropanoic acid derivatives for treating neurodegenerative disorders | |
| EP3313387A4 (en) | METHOD AND COMPOSITION FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES | |
| GB201701404D0 (en) | Therapies for treating inflammatory disorders | |
| GB201701455D0 (en) | Neurodegenerative disorders | |
| IL289018A (en) | Methods for treating neurodegenerative disorders | |
| HK40072836A (en) | Methods for treating neurodegenerative disorders | |
| HK40069546A (en) | Methods for treating neurodegenerative disorders | |
| HK40019969A (en) | Methods for treating neurodegenerative disorders | |
| HK40017730A (en) | Methods for treating mitochondrial disorders | |
| PT3420084T (pt) | Nova abordagem para tratamento de disfunções inflamatórias |